Amurek Tablet 50 mg (Eperisone Hydrochloride)

Adult dose

Eperisone hydrochloride 50 mg orally three times a day after meals. Adjust dosage as appropriate based on age and symptoms.

This medication should not be used in certain patients. Firstly, individuals who have had allergic reactions to this medication should avoid taking it. Secondly, this medication is not suitable for patients with severe weakness due to myasthenia gravis. Thirdly, since it contains lactose, patients with genetic lactose intolerance or related disorders should not take it. Additionally, caution is warranted when using this medication. Individuals with a history of drug allergies should take it with care, and patients with liver dysfunction should be cautious as it may adversely affect liver health. Rarely, a serious allergic reaction such as shock may occur as a side effect, thus if symptoms arise, the medication should be discontinued immediately, and treatment should be sought. As liver function test values may increase, if any abnormal symptoms occur, usage should be stopped and a consultation with a physician is advised. It may also affect kidney function, so if proteinuria or blood test abnormalities are found, caution is necessary. Reactions such as anemia, skin rash, and itching may occur as hypersensitivity reactions. Neurological symptoms have been reported including insomnia, drowsiness, headache, and limb paralysis, and rarely muscle stiffness or tremors may occur. Gastrointestinal issues may include nausea, vomiting, loss of appetite, and abdominal pain, so caution should be exercised if symptoms arise. Urinary symptoms such as difficulty urinating or urinary incontinence may rarely appear. Systemically, weakness, dizziness, and reduced muscle tone have been reported; redness of the face, sweating, and swelling may also occur. This medication can cause serious skin adverse reactions such as Stevens-Johnson syndrome. Therefore, if fever, rash, blisters, itching, conjunctival injection, or oral inflammation occur, it should be discontinued immediately. If weakness, staggering, or drowsiness develops during treatment, it is advisable to reduce or discontinue the medication dosage. This medication may cause drowsiness and reduced attention, so caution should be exercised when driving or operating hazardous machinery. Caution is also necessary when taken with similar medications or specific muscle relaxants, as visual disturbances may occur. Women who are pregnant or may become pregnant should use this medication only when the benefits outweigh the risks, as its safety has not been established. Lactating women are advised to avoid taking it if possible; if necessary, it is recommended to discontinue breastfeeding. Safety in pediatric patients has not been sufficiently confirmed, so it should be used cautiously in children. Elderly individuals may have decreased bodily functions, so they should take it with caution, including potential dosage reductions.

Serious side effects

Shock, liver dysfunction indicated by increased ALT, AST, ALP, kidney dysfunction indicated by proteinuria and increased BUN, anemia, anaphylactic reactions, angioedema, toxic epidermal necrolysis and mucocutaneous ocular syndrome (Stevens-Johnson syndrome), fever, severe rash, blisters, itching, conjunctival injection, stomatitis.

Mild side effects

• Rash
• itching
• insomnia
• drowsiness
• headache
• body stiffness
• limb tremors
• nausea
• vomiting
• loss of appetite

This medication should be stored in a sealed container to prevent air and moisture from entering. It is advisable to maintain the storage temperature between 1°C and 30°C at room temperature.

Appearance

White round film-coated tablet

Package unit

30 tablets/bottle, 500 tablets/bottle